Sanofi Offers New Payment Model for Drug Discount Program

Sanofi SA is proposing a new way to discount drugs for health providers under a federal drug discount program for providers that treat low income and uninsured patients.

The drugmaker Friday announced the launch of its “340B Credit Model,” which will require health providers under the federal 340B Drug Pricing Program to show details of their pharmacy and medical claims before receiving a drug discount.

Sanofi’s model follows moves by Johnson & Johnson and Eli Lilly & Co., to institute similar models. Those two drugmakers sued the US Health Resources and Services Administration, the agency that administers the ...